Home › Funds › Maverick Capital › TXG
Maverick Capital position in TXG
10X Genomics Inc CL · Industrials
Maverick Capital reported holding 538,008 shares of TXG (10X Genomics Inc CL) in its Q3 2026 13F filing — a position valued at US$48.6M, representing 0.40% of its reported portfolio and ranking #40 among its reported holdings. Maverick Capital first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Maverick Capital's TXG position evolved
Maverick Capital first disclosed a stake in TXG in Q3 2026 at 538,008 shares (US$48.6M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 538.01K | $48.61M | New |
About TXG and 13F data
TXG (10X Genomics Inc CL) is a Industrials company. 53 other funds we track also report a position in TXG — the largest reported positions include ARK Invest (US$566.8M), Quantinno Capital Management LP (US$333.5M), Castle Hook Partners LP (US$229.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TXG
- ARK Invest 6.27M sh · $566.83M · Q3 2026
- Quantinno Capital Management LP 3.69M sh · $333.49M · Q3 2026
- Castle Hook Partners LP 2.54M sh · $229.89M · Q3 2026
- Amova Asset Management Americas, Inc. 2.26M sh · $203.94M · Q3 2026
- Casdin Capital 1.05M sh · $94.88M · Q3 2026
- MAVERICK CAPITAL LTD 538.01K sh · $48.61M · Q3 2026
- Sands Capital Alternatives, LLC 481.77K sh · $43.53M · Q3 2026
- Blue Water Life Science Advisors, LP 391.40K sh · $35.37M · Q3 2026
More on Maverick Capital
FAQ
How long has Maverick Capital held TXG?
Maverick Capital has disclosed TXG holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Maverick Capital's current position in TXG?
As of Q3 2026, Maverick Capital holds 538.01K shares of TXG (10X Genomics Inc CL), valued at $48.61M, representing 0.40% of its reported portfolio and ranking #40.
Has Maverick Capital been buying or selling TXG?
In the latest 13F filing (Q3 2026), Maverick Capital newly opened its position in TXG.
Which other funds hold TXG?
Other major institutional holders of TXG include ARK Invest, Quantinno Capital Management LP, Castle Hook Partners LP, among 53 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.